Last10K.com

Fresenius Medical Care Ag Co. Kgaa (FMS) SEC Filing 6-K Foreign Issuer report for the period ending Wednesday, February 20, 2019

Fresenius Medical Care Ag Co. Kgaa

CIK: 1333141 Ticker: FMS

 

 

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

 

Pursuant to Rule 13a-16 or 15d-16 of the

Securities Exchange Act of 1934

 

For the month of February 2019

 

FRESENIUS MEDICAL CARE AG & Co. KGaA

(Translation of registrant’s name into English)

 

Else-Kröner Strasse 1

61346 Bad Homburg

Germany

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F  x                                                                            Form 40-F  o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): o

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 

Yes  o                                                                                                                   No  x

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82

 

 

 


 

EXHIBITS

 

Exhibit 99.1

 

Press Release issued on February 21, 2019.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

DATE: February 21, 2019

 

 

FRESENIUS MEDICAL CARE AG & Co. KGaA,

 

a partnership limited by shares, represented by:

 

 

 

FRESENIUS MEDICAL CARE MANAGEMENT AG, its

 

General Partner

 

 

By:

/s/ RICE POWELL

 

 

 

 

Name:

Rice Powell

 

 

 

 

 

 

Title:

Chief Executive Officer and Chairman of the Management Board of the General Partner

 

 

By:

/s/ MICHAEL BROSNAN

 

 

 

 

 

Name:

Michael Brosnan

 

 

 

 

 

 

Title:

Chief Financial Officer and Member of the Management Board of the General Partner

 

3


View differences made from one to another to evaluate Fresenius Medical Care Ag Co. Kgaa's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 6-K Foreign Issuer Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Fresenius Medical Care Ag Co. Kgaa.

Continue

Assess how Fresenius Medical Care Ag Co. Kgaa's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Fresenius Medical Care Ag Co. Kgaa's Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors

Continue

Tools

Material Contracts, Statements, Certifications & more

Fresenius Medical Care Ag Co. Kgaa provided additional information to their SEC Filing as exhibits

Ticker: FMS
CIK: 1333141
Form Type: 6-K Foreign Issuer Report
Accession Number: 0001104659-19-009728
Submitted to the SEC: Thu Feb 21 2019 7:51:01 AM EST
Accepted by the SEC: Thu Feb 21 2019
Period: Wednesday, February 20, 2019
Industry: Health And Allied

External Resources:
Stock Quote
Social Media

Bookmark the Permalink:
https://last10k.com/sec-filings/fms/0001104659-19-009728.htm